| 标题 |
Abstract CT019: Preliminary safety and antitumor activity of zoldonrasib (RMC-9805), an oral, RAS(ON) G12D-selective, tri-complex inhibitor in patients with KRAS G12D non-small cell lung cancer (NSCLC) from a phase 1 study in advanced solid tumors |
| 网址 | |
| DOI |
10.1158/1538-7445.am2025-ct019
doi
|
| 其它 |
期刊:Cancer Research 作者:Kathryn C. Arbour; Tanvetyanon Tawee; Rona Yaeger; Aparna R. Parikh; Paul Oberstein; et al 出版日期:2025-05-22 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)